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doi:10.1Laparoscopic fundoplication for gastroesophageal reflux disease has been associated with excellent symptom
control. Compared with medical treatment, laparoscopic Nissen fundoplication has shown favorable control
of typical reflux symptoms. However, in approximately 2% to 17% of patients, surgical treatment fails. The
role of reoperative repair for reflux disease and the factors that contribute to it are examined. (J Thorac Cardi-
ovasc Surg 2012;144:S71-3)Approximately 44% of patients experience reflux-related
symptoms once a month and approximately 7% to 10%
of patients experience reflux-related symptoms on a daily
basis.1 Most of these conditions are treated with diet
modifications and medications. Proton pump inhibitors,
the most popular treatment, generate more than $13 bil-
lion in revenue and are the third most commonly pre-
scribed drug class.2,3 However, more recent data have
indicated an increase risk of osteoporosis and fractures,
increased Clostridia dificille infections and pneumonia,
and increased interaction with cardiac medications with
chronic proton pump inhibitor use.4,5 Additionally,
chronic histamine-2 blockers have been associated with
some cognitive dysfunction.6 Patients with severe chronic
obstructive pulmonary disease are also more prone to ex-
acerbations when accompanied by gastroesophageal re-
flux disease (GERD) symptoms.7
Although some debate remains regarding medical vs
surgical correction of reflux disease, a 2010 Cochrane sys-
tematic review of randomized controlled trails demon-
strated an improved outcome after laparoscopic Nissen
fundoplication.8 In addition, a meta-analysis of almost
1700 patients demonstrated a decreased incidence of ade-
nocarcinoma and increased regression of Barrett’s esopha-
gus, supporting the benefit of surgical correction of reflux
disease.9
The long-term results after surgery have demonstrated
high satisfaction for up to 97% of patients at 5 years.10-13
However, 2% to 17% of patients have some level of
failure after surgery.14 These might be related to recurrent
reflux disease, regurgitation, or dysphagia. Approximately
4% to 6% of patients have severe, persistent, and refractory
symptoms that require reoperative therapy.e Division of Thoracic Surgery, Brigham and Women’s Hospital, Boston,
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The Journal of Thoracic and CaCAUSES OF FAILURE
The common causes of failure include recurrent hiatal
hernia, a slipped or displaced wrap, too tight of a wrap,
a misplaced wrap, disruption of the wrap, or a missed
diagnosis.15 The hiatal hernia is the most common cause
of failure. This results in migration of the wrap above the
hiatus and can result in both reflux and dysphagia.16,17 It
might be related to inadequate closure of the crural fibers
after repair or an innate weakness within the fibers that
predisposes it to dilation.17 Some have argued for the use
of mesh repair in the case of large hiatal openings.18 A pro-
spective randomized trial using a biologic prosthesis dem-
onstrated a 60% reduction in hernias at 6 months.
Some of this could also be related to inadequate mobili-
zation of the esophagus or a short esophagus.19 Although
the existence of a true shortened esophagus has been de-
bated, chronic damage from reflux and compression from
a hiatal hernia can result in difficulty placing the gastro-
esophageal junction comfortably in the abdomen.20,21
A slipped or displaced wrap can result when the body of
the stomach slides above the wrap, resulting in an hourglass
stomach. The portion of stomach above the wrap can cause
severe reflux symptoms, because it serves as a reservoir.
The wrap also becomes obstructive, causing severe dyspha-
gia symptoms. Amisplaced wrap can also result in a twisted
or asymmetric wrap, leading to recurrent reflux. This usu-
ally occurs when the wrap is constructed using the body
of the stomach as opposed to the fundus. Finally, physio-
logic factors such as obesity and straining also contribute
to the recurrence of symptoms.15,17,22EVALUATION
Although a recurrence of symptoms such as heartburn
can lead to a presumptive diagnosis of recurrence, symp-
toms alone have not correlated well with actual recur-
rence.23 A University of California, San Francisco, study
of 822 patients demonstrated that only 70% of patients
with a GERD diagnosis had positive findings on a pH
study.24 Heartburn and regurgitation were as common in
those with a confirmed study as in those without. Hence,
symptoms alone are not enough to confirm recurrence. Post-
operative monitoring of GERD will result in an abnormal
pH in only 20% of patients.25 An objective evaluation re-
mains critical to the evaluation. This includes upperrdiovascular Surgery c Volume 144, Number 3 S71
TABLE 1. Recurrent symptoms and causes of failure
Variable Incidence (n)
Common recurrent symptoms 4750
Recurrent reflux 1912 (41.7)
Dysphagia 760 (16.6)
Recurrent reflux and dysphagia 184 (4.0)
Anatomic abnormality 114 (2.5)
Gas bloat syndrome 31 (0.7)
Miscellaneous 148 (3.2)
Not reported 1435 (31.3)
Anatomic causes of failure 3175
Intrathoracic wrap migration 885 (27.9)
Wrap disruption 722 (22.7)
Telescoping 448 (14.1)
Paraesophageal hiatal herniation 195 (6.1)
Hiatal disruption 167 (5.3)
Tight wrap 168 (5.3)
Stricture 60 (1.9)
Data in parentheses are percentages. Data from Fernee et al.15
Abbreviation and Acronym
GERD ¼ gastroesophageal reflux disease
Session VII: Esophagus—Benign Weegastrointestinal/barium swallow, pH monitoring, manome-
try, and upper endoscopy.
A barium contrast study and endoscopy are important in
the evaluation of the anatomy of the wrap. It can illustrate
the location of the wrap above or below the hiatus, as
well as the geometry of the wrap. Some slipped and twisted
wraps can be identified by inspection using endoscopy.26
Manometry is also important to rule out a missed diagnosis
such as achalasia.15
pH monitoring remains the reference standard, with sen-
sitivity, specificity, and accuracy approaching 96%.27 Com-
bined impedance and pH monitoring can also detect both
acid and nonacid reflux disease. Studies have demonstrated
a high correlation with GERD with high reproducibility.28
The determination of the bolus transit time can also be
used as an evaluation of esophageal function.
SURGICAL GOALS
Reoperative surgery for reflux disease should start with
reestablishing the normal anatomy. This involves taking
down the adhesions surrounding the wrap and hiatus. The
wrap should be fully mobilized. The normal gastric anat-
omy should be achieved by unfurling the wrap from the gas-
troesophageal junction. One must be careful to avoid injury
to the vagus nerves in this process. Once a normal gastric
anatomy has been achieved, the hiatus and esophagus can
be fully examined to better identify the cause of failure. Ad-
ditional mobilization of the esophagus can be achieved
through the hiatus, separating it from the aorta and pericar-
dium. Additionally, the esophageal length and the need for
a Collis gastroplasty can be determined.19-21
Once the esophageal length as been addressed, the wrap
should be reformed over a bougie.29 Generally, a loose Nis-
sen fundoplication is adequate for repair. This can be per-
formed by using a large bougie to help size the wrap. Some
patients in whom the initial complaint is dysphagia might
benefit from a Toupet fundoplication, although studies have
favored laparoscopic Nissen fundoplication for long-term
treatment of reflux, with very little difference in dysphagia
symptoms.30-33 Hiatal closure is then accomplished. If
a hiatal hernia is the cause of failure, consideration should
be made to place mesh support on the crura.18
OUTCOMES
A large meta-analysis of more than 4500 cases by Furnee
and colleagues15 reported the largest review of reoperative
fundoplication and included both open and laparoscopic
series (Table 1). Mortality after reoperation was 1.3%,S72 The Journal of Thoracic and Cardiovascular Surgalthough none occurred in the laparoscopic group. Symp-
tomatic success was seen in 81% of the laparoscopic pa-
tients; 78% of the patients had successful objective
outcomes. Common complications included gastric or
esophageal perforations, although most were recognized
immediately and corrected laparoscopically. Khajanchee
and colleagues34 reported a laparoscopic series of 13 years
that also demonstrated success in 75% of reoperative pa-
tients, with complete to near complete resolutions of symp-
toms. An additional 14% had improved symptoms.34 Of
these patients, 81% had wrap herniation seen on the upper
gastrointestinal study. The findings from the quality of life
evaluations after reoperative surgery also approached gen-
eral population norms.35,36CONCLUSIONS
Reoperative laparoscopic surgery for recurrent reflux
symptoms can be achieved with minimal mortality risk. A
full evaluation is necessary to understand the cause of recur-
rent symptoms. Symptoms alone are often not enough and
often do not correlate with actual recurrence. The surgical
goals are to return the normal gastric anatomy and evaluate
the entire hiatal complex before reforming the wrap. Objec-
tive and symptomatic success can be achieved in approxi-
mately 80% to 90% of patients and should be considered
for persistent recurrent disease.References
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